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Abstract
Background: Contamination of endoscopy equipment by Helicobacter pylori (H. pylori) frequently
occurs after endoscopic examination of H. pylori-infected patients. In the hospital, manual pre-
cleaning and soaking in glutaraldehyde is an important process to disinfect endoscopes. However,
this might not be sufficient to remove H. pylori completely, and some glutaraldehyde-resistant
bacteria might survive and be passed to the next patient undergoing endoscopic examination
through unidentified mechanisms. We identified an Imp/OstA protein associated with
glutaraldehyde resistance in a clinical strain, NTUH-C1, from our previous study. To better
understand and manage the problem of glutaraldehyde resistance, we further investigated its
mechanism.
Results: The minimal inhibitory concentrations (MICs) of glutaraldehyde andexpression of imp/
ostA RNA in 11 clinical isolates from the National Taiwan University Hospital were determined.
After glutaraldehyde treatment, RNA expression in the strains with the MICs of 4–10 μg/ml was
higher than that in strains with the MICs of 1–3 μg/ml. We examined the full-genome expression
of strain NTUH-S1 after glutaraldehyde treatment using a microarray and found that 40 genes were
upregulated and 31 genes were downregulated. Among the upregulated genes, imp/ostA and msbA,
two putative lipopolysaccharide biogenesis genes, were selected for further characterization. The
sensitivity to glutaraldehyde or hydrophobic drugs increased in both of imp/ostA and msbA single
mutants. The imp/ostA and msbA double mutant was also hypersensitive to these chemicals. The
lipopolysaccharide contents decreased in individual imp/ostA and msbA mutants and dramatically
reduced in the imp/ostA  and  msbA  double mutant. Outer membrane permeability assay
demonstrated that the imp/ostA and msbA double mutation resulted in the increase of outer
membrane permeability. Ethidium bromide accumulation assay demonstra t e d  t h a t  M s b A  w a s
involved in efflux of hydrophobic drugs.
Conclusion: The expression levels of imp/ostA and msbA were correlated with glutaraldehyde
resistance in clinical isolates after glutaraldehyde treatment. Imp/OstA and MsbA play a synergistic
role in hydrophobic drugs resistance and lipopolysaccharide biogenesis in H. pylori.
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Background
Helicobacter pylori was first isolated from the gastric
mucosa of a patient with gastritis and peptic ulceration by
Marshall and Warren in 1982 [1]. It is an important
human pathogen, responsible for type B gastritis and pep-
tic ulcers. Furthermore, infection by H. pylori is a risk fac-
tor for gastric adenocarcinoma and for lymphoma in the
mucosa-associated lymphoid tissue of the stomach in
humans [2-5].
H. pylori is believed to be transmitted from person to per-
son by oral-oral or oral-fecal routes [6]. However, another
possible route involves transmission during endoscopic
examination of patients because contamination of endos-
copy equipment by H. pylori frequently occurs after endo-
scopic examination of H. pylori-infected patients [7-9].
Because H. pylori is prevalent in the population [10], it is
important to prevent its transmission. In the hospital,
manual pre-cleaning and soaking in glutaraldehyde is an
important process used to disinfect endoscopes [7,11].
However, endoscopic disinfection might not be sufficient
to remove H. pylori completely [12,13]. Some glutaralde-
hyde-resistant bacteria might survive and be passed to the
next person undergoing endoscopic examination through
unidentified mechanisms. Therefore, it is an important
issue to clarify the mechanism of glutaraldehyde resist-
ance.
In our previous study, we demonstrated that the Imp/
OstA protein was associated with glutaraldehyde resist-
ance in a clinical strain of H. pylori [14]. OstA (organic sol-
vent tolerance) [15] has also been called imp (increased
membrane permeability) [16], and was recently named
lptD  in  Escherichia coli [17]. Imp/OstA exists widely in
Gram-negative bacteria and participates in biogenesis of
the cell envelope. It is an essential outer membrane pro-
tein in E. coli, depletion mutation of imp/ostA results in the
formation of aberrant membranes [18]. Furthermore,
Imp/OstA forms a complex with the RlpB lipoprotein and
is responsible for lipopolysaccharide (LPS) assembly at
the surface of the cell [17,19]. In addition, it mediates the
transport of LPS to the surface in Neisseria meningitidis
[20].
To further investigate the mechanism of glutaraldehyde
resistance, we monitored the minimum inhibitory con-
centrations (MICs) and the expression of imp/ostA  and
Imp/OstA protein after glutaraldehyde treatment in 11
clinical isolates. Full-genome expression was also studied
by microarray analysis; 40 genes were upregulated and 31
genes were downregulated in NTUH-S1 after glutaralde-
hyde treatment. Among the upregulated genes, msbA, was
selected for further study. MsbA is an essential inner mem-
brane protein in E. coli and a member of the ABC trans-
porter superfamily of proteins [21]. MsbA produced in the
Gram-positive organism Lactococcus lactis is capable of
conferring drug resistance to the organism [22]. In addi-
tion,  msbA  is not essential in N. meningitidis and this
organism can survive without LPS [23]. In E. coli, msbA
was implicated in lipid A-core moiety flipping from the
inner leaflet to outer leaflet of the inner membrane
[24,25], and then Imp/RlpB protein complex was respon-
sible for transport of LPS from the periplasm to the outer
leaflet of the outer membrane [17]. Here we showed that
imp/ostA and msbA might be synergistic in hydrophobic
drugs resistance and LPS transport in H. pylori.
Methods
Chemicals
Glutaraldehyde was purchased from Electron Microscopy
Sciences (Hatfield, PA). Chloramphenicol, erythromycin,
kanamycin, novobiocin, rifampicin, ethidium bromide,
and carbonyl cyanide m-chlorophenylhydrazone (CCCP)
were purchased from Sigma Chemical Co (St Louis, MO).
Bacterial strains and culture conditions
Clinical isolates were collected from National Taiwan
University Hospital (NTUH) as previously described [26].
H. pylori strains were grown on Columbia agar plates con-
taining 5% sheep blood under microaerophilic condi-
tions (5% O2, 10% CO2, and 85% N2) at 37°C. For
microarray analysis, we selected a rapidly growing strain
NTUH-S1 with a higher MIC (MIC = 6 μg/ml) to glutaral-
dehyde from a patient with gastritis to study gene expres-
sion. To screen for mutant strains, blood agar plates were
supplemented with 4 μg/ml chloramphenicol or 10 μg/ml
kanamycin. To screen for imp/ostA and msbA double dele-
tion mutant or complementation strains, blood agar
plates were supplemented with 4 μg/ml chloramphenicol
and 10 μg/ml kanamycin.
Determination the MICs of glutaraldehyde and 
hydrophobic drugs in H. pylori
The MICs of glutaraldehyde and hydrophobic drugs
(erythromycin, novobiocin, rifampicin, and ethidium
bromide) were determined by the agar dilution method.
Suspension of H. pylori was adjusted to 107 cells/ml. Five
microliters of bacterial suspensions were spotted on
blood agar plates supplemented with different concentra-
tions of drugs. Results were observed after 72 h incubation
under microaerophilic condition at 37°C.
RNA slot blot hybridization
Four strains with the MICs of 7–10 μg/ml glutaraldehyde
(designed numbers 1~4), four with the MICs of 4–6 μg/
ml glutaraldehyde (numbers 5~8), and three with the
MICs of 1–3 μg/ml glutaraldehyde (numbers 9~11) were
grown on Columbia blood agar plates for 48 h, and fur-
ther passaged on Columbia blood agar plates or 0.5 μg/ml
glutaraldehyde-containing blood agar plates for 48 h.BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
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Since 0.5 μg/ml was the half concentration of the mini-
mum MIC for the 11 strains, we defined this as the induc-
tion concentration. Subsequently, RNA was extracted
from the bacteria with or without glutaraldehyde treat-
ment. Total RNA from each H. pylori clinical isolate was
extracted as described previously [27]. Ten micrograms of
total RNA was transferred onto a nylon membrane using
a slot-blot system (Hoefer, Holliston, MA). The mem-
brane was hybridized with DNA probes specific for 23S
rRNA (0.9 kb PCR-amplified 23S rRNA-specific fragment
using the forward primer: 5'-ATTGGAGGGAAG-
GCAAATCC-3' and the reverse primer: 5'-ATCACTAT-
GACCGACTTTCG-3'),  imp/ostA  (0.8 kb PCR-amplified
imp/ostA-specific fragment using the forward primer: 5'-
CATTGATAACCCCATTTGGC-3' and the reverse primer:
5'-GCACATTCAAAGCGTTTTGC-3'), and msbA  (0.8 kb
PCR-amplified msbA-specific fragment using the forward
primer: 5'-TAGCGTTAGTGGGGTTAGTC-3' and the
reverse primer: 5'-ACACCCTTTGAGTGACAACG-3')
labeled with DIG by PCR. Detection was performed with
the DIG Luminescent Detection kit (Roche Diagnostics,
Indianapolis, IN) according to the manufacturer's instruc-
tions.
RNA isolation and quantitative real-time PCR
It takes 48 to 72 h to recover colonies when H. pylori were
grown on blood agar plates. A previous report also
detected consistent RNA expression levels changes of H.
pylori after 48 h of growth on acidified blood agar plates
[27]. H. pylori NTUH-S1 was grown on Columbia blood
agar plates for 48 h, and further passaged on Columbia
blood agar plates or 0.5 μg/ml glutaraldehyde-containing
blood agar plates for 48 h. RNA was extracted by the QIA-
GEN RNeasy column purification kit (Qiagen, Hilden,
Germany) according to the manufacturer's instructions.
Total RNA was quantified with a spectrophotometer and
visualized on an ethidium bromide stained agarose gel.
Total RNA served as a template for cDNA synthesis using
the SuperScript II Reverse transcriptase (Invitrogen,
Carlsbad, CA). Synthesis reactions were started with 1.5
μg total RNA per 20 μl reaction mixture. All reactions were
normalized to the level of the 16S rRNA gene [28]. In real-
time RT-PCR, amplification and detection of the cDNAs
were monitored using the KAPA SYBR FAST qPCR kit
(Kapabiosystems, Boston, MA) in an ABI 7900 thermocy-
cler (Applied Biosystems, Carlsbad, CA). Gene-specific
primers  imp/ostA  RT (F): 5'-TTTGTCTTTAGGGCTTT-
GGAATG-3', imp/ostA RT (R): 5'-GCACGAAGGAATTTTTA-
GATTGC-3' and 16S rRNA RT (F):5'-
TGCGAAGTGGAGCCAATCTT-3', 16S rRNA RT (R): 5'-
GGAACGTATTCACCGCAACA-3' were used for amplifica-
tion of cDNAs in this experiment. For the imp/ostA gene,
the calculated threshold cycle (Ct) was normalized to the
Ct of the 16S rRNA gene from the same cDNA sample
before the fold change was calculated using the ΔΔCt
method as described previously [29].
Western blots analysis of cell extracts
Eleven strains (numbers 1~11, the same isolates as previ-
ously described in RNA slot blot hybridization experi-
ments) were selected and grown on Columbia blood agar
plates for 48 h, and further passaged on Columbia blood
agar plates or 0.5 μg/ml glutaraldehyde-containing blood
agar plates for 48 h. Bacteria were harvested by centrifuga-
tion. Cells were washed in phosphate-buffered saline
(PBS), resuspended in lysis buffer (50 mM Tris-HCl, 500
mM NaCl, 0.1% SDS, 10% glycerol), and lysed by sonica-
tion. Total protein concentration was determined by using
the Bio-Rad protein assay (Bio-Rad, Hercules, CA). Sam-
ples were loaded at identical protein concentrations from
total cell extracts for Western blot analysis. SDS-PAGE was
transferred to nitrocellulose for immunological detection.
Membrane was blocked with 5% skimmed milk in TBS
overnight at 4°C. Subsequently, membrane was incu-
bated with anti-OstA polyclonal antibody [14] diluted
1:500 with 5% skimmed milk in TTBS (0.5% Tween-20)
for 1 h at room temperature. Horseradish peroxidase-con-
jugated anti-rat IgG diluted 1:3000 with 5% skimmed
milk in TTBS (0.5% Tween-20) was added and membrane
was incubated for 1 h at room temperature. The mem-
brane was washed three times with TTBS (0.5% Tween-
20) between the incubation steps. Electrochemilumines-
cence (Amersham Biosciences, Fairfield, CT) was used for
detection.
RNA isolation and microarray analysis of H. pylori NTUH-
S1
H. pylori NTUH-S1 was grown on Columbia blood agar
plates for 48 h and further passaged on Columbia blood
agar plates or 3 μg/ml glutaraldehyde-containing blood
agar plates for 48 h. RNA was extracted using the QIAGEN
RNeasy column purification kit (Qiagen) according to the
manufacturer's instructions.
cDNA was synthesized according to the SuperScript™ indi-
rect cDNA Labeling System (Invitrogen). cDNA was then
purified using the S.N.A.P column purification (Invitro-
gen) according to the manufacturer's instructions.
Aminoallyl dUTP-labeled cDNA was resuspended in 2 ×
coupling buffer and labeled with either Alexa Fluor 555 or
647 according to the manufacturer's protocol (Molecular
Probes, Eugene, OR). Labeled cDNA was mixed together
and purified by S.N.A.P column purification. Then, the
labeled cDNA was concentrated with a Microcon YM-30
column (Millipore, Billerica, MA).
The Institute for Genomic Research (TIGR) provided a H.
pylori whole-genome microarray. It consisted of 2,572 70-BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
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mer oligonucleotides, printed in quadruplicate and repre-
senting open reading frames from H. pylori 26695 and
strain J99. Labeled cDNA was resuspended in filtered
hybridization buffer (50% formamide, 5 × SSC, 0.1%
sodium dodecyl sulfate, 0.1 M DTT, and 0.6 μg/ml salmon
sperm DNA), denatured at 95°C for 5 min, and flicked for
an additional minute. It was then denatured for another 5
min. The labeled probe was applied to the pre-hybridized
microarray and placed in a hybridization chamber at
42°C for 16~20 h. Microarray scanning and analysis were
performed on a scanner (GenePix 4000B with GenePix
Pro 5.0 software; Axon, Foster City, CA).
Processed microarray data files have been deposited in the
Center for Information Biology Gene Expression Data-
base (CIBEX; http://cibex.nig.ac.jp) under accession
number CBX86.
Construction of imp/ostA and msbA deletion mutants
The gene encoding Imp/OstA with the upstream and
downstream 500 bp flanking region was amplified with
the genomic DNA of wild-type NTUH-S1 by PCR. The for-
ward primer was 5'-ATGCACTCTCCAAATTTAGA-3', and
the reverse primer was 5'-GGGGCTAGGATAGGTTCTAA-
3'. It was then cloned into a pGEM-T easy vector
(Promega, Madison, WI).
The gene encoding MsbA with the upstream 458-bp and
downstream 474-bp flanking regions was amplified with
the genomic DNA of wild-type NTUH-S1. PCR was per-
formed using the forward primer, 5'-ACGACAGGAAAC-
CCTTTAGG-3' and the reverse primer was 5'-
AGCGTAATAAACAGGCACGC-3'. It was also cloned into
a pGEM-T easy vector (Promega).
The imp/ostA and msbA genes were deleted by inverse PCR,
and a chloramphenicol-resistant cassette (a gift from Dr.
D. E. Taylor, University of Alberta) with its coding region
(from the 1-bp start codon to the 624-bp stop codon) was
then cloned into the flanking regions to replace the full-
length imp/ostA or msbA gene. This plasmid was natural
transformed into the wild-type NTUH-S1 strain to gener-
ate deletion mutants. Chromosomal DNA of the trans-
formants was checked by PCR with primers external and
internal to the replacement site to verify the double-cross-
over event.
Complementation of imp/ostA and msbA
An  imp/ostA  complementation strain of NTUH-S1 was
constructed as described previously [14]. The promoter
site of msbA gene was predicted by using a tool available
at the following website: http://www.fruitfly.org/
seq_tools/promoter.html. The msbA gene containing the
predicted promoter region (upstream 73 bp) was
obtained by PCR using the forward primer: 5'-
CCAATCGCTTTAAGCTG-3', and the reverse primer: 5'-
TTAGCATTCTGTCAAACGCC-3'. Then the DNA fragment
was cloned into the pGEM-T easy vector (Promega). The
msbA gene with its promoter region was cut from the con-
structed pGEM-T easy vector and ligated into the NruI site
of the shuttle vector pHel3 (plasmid pHel3 was a gift from
Dr. R. Haas, Max-Planck-Institute für Biologie, Tübingen,
Germany). The constructed shuttle vector was natural
transformed into an msbA deletion mutant strain to gen-
erate the msbA complementation strain.
Construction of the imp/ostA and msbA double deletion 
mutant
The gene encoding MsbA with its upstream 458-bp and
downstream 474-bp flanking region was cloned into the
pGEM-T easy vector as described above. A kanamycin-
resistant gene aphA-3 from Campylobacter jejuni was then
cloned between the flanking regions to replace the full
length msbA gene. This plasmid was natural transformed
into the wild-type NTUH-S1 strain to generate the dele-
tion mutant. Chromosomal DNA of the transformants
was checked by PCR with primers external and internal to
the replacement site to verify the double-crossover event.
Then, chromosomal DNA from msbA  deletion mutant
strain (Kmr) was natural transformed into the imp/ostA
deletion mutant to obtain a double deletion mutant
strain. It was also confirmed by PCR with primers external
and internal to the msbA gene replacement site.
Southern blotting
Approximately 5 μg of genomic DNA from H. pylori
NTUH-S1 and the mutants was digested by Hind III and
incubated at 37°C overnight for complete digestion. The
digoxigenin-labeled imp/ostA and msbA probes (primers
were the same as those described for slot blot) was gener-
ated by PCR. Hybridization and detection were performed
with the DIG Luminescent Detection kit (Roche) accord-
ing to the manufacturer's instructions.
Proteinase-K digested H. pylori
The procedure was followed as described previously [30].
H. pylori cells were collected and adjusted to a concentra-
tion of 2.5 × 109 cells/ml in PBS. Bacteria were boiled with
150 μl sample dye for 10 min at 100°C to disrupt the
whole cells. Subsequently, the whole cell lysates were
treated with proteinase K (Sigma) for 60 min at 60°C in a
water bath. Then, 2.5 × 108 cells/ml were analyzed by 12%
SDS-PAGE and stained with silver. The protein concentra-
tion of the 2.5 × 108 cells/ml was also determined by using
the Bio-Rad protein assay (Bio-Rad) to serve as a loading
control.BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
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Immunoblots of LPS from H. pylori with anti-Lewis (Le) 
monoclonal antibody
H. pylori strains that have been screened serologically [31-
33], and a previous study suggested that Asian isolates
express predominantly type 1 (Lea, Leb) antigens com-
pared to Western strains (predominantly expressing type
2 Lex  and Ley  determinants) [34]. We also primarily
detected the Lewis antigen of NTUH-S1 with anti-Lea and
anti-Leb antibody. Equivalent amounts of protein were
loaded in each well and transferred to nitrocellulose for
immunological detection with anti-Lea or anti-Leb mono-
clonal antibody (Seikagaku Corporation, Tokyo). For
detection of Lewis antigen in proteinase K-digested whole
cell lysates, nitrocellulose membrane was blocked with
5% skimmed milk in PBS for 1 h at room temperature.
Subsequently, membrane was incubated with anti-Lea or
anti-Leb antibody diluted 1:3000 with 5% skimmed milk
in PBS overnight at 4°C. Horseradish peroxidase-conju-
gated anti-mouse IgG diluted 1:5000 with 5% skimmed
milk in PBS was added and membrane was incubated for
1 h at room temperature. The membrane was washed
three times with PBST (0.05% Tween-20) between the
incubation steps. Electrochemiluminescence (Amersham
Biosciences) was used for detection. Whole cells of the Lex
and Ley antigen-expressing  H. pylori 26695 strain [35]
were used as a negative control in Western blots to ensure
the specificity of the anti-Lea or anti-Leb antibody.
Measurement of outer membrane permeability by 
ethidium bromide
Outer membrane permeability can be measured by the
fluorescence of the ethidium-polynucleotide complex in
the cell because ethidium bromide displays approxi-
mately a 10-fold increase in fluorescence quantum yield
upon binding to DNA [36]. The assay was modified as
described previously [37]. Briefly,H. pylori were grown on
Columbia blood agar plate for 48 h. Then, bacteria were
pelleted and washed twice with ice-cold 50 mM potas-
sium phosphate (pH 7.0) containing 5 mM MgSO4. Cells
were resuspended in 1 ml of potassium phosphate buffer
(pH 7.0) at an optical density (OD600) of 0.5 and incu-
bated for 30 min at 37°C in the presence of 10 μM of
CCCP to deplete cells of metabolic energy. Subsequently,
cells were washed three times in ice-cold potassium phos-
phate (pH 7.0) containing 5 mM MgSO4 and loaded with
10 μg/ml ethidium bromide. At the 40-min time point,
the increase in ethidium bromide fluorescence intensity
was measured in Gemini XPS spectrofluorimeter (Molec-
ular Devices, Sunnyvale, CA) at 30°C with the excitation
wavelength set at 500 nm and the emission wavelength at
580 nm. Each measurement was repeated three times.
Ethidium bromide accumulation assay
The assay was modified as described previously [38].
Briefly,H. pylori were grown on Columbia blood agar plate
for 48 h. Then, bacteria were pelleted and washed twice
with ice-cold 50 mM potassium phosphate (pH 7.0) con-
taining 5 mM MgSO4. Cells were resuspended in 1 ml of
potassium phosphate buffer (pH 7.0) at an optical density
(OD600) of 0.5. Cells were preloaded with 10 μg/ml ethid-
ium bromide. At the 12-min time point, 10 μM of CCCP
was added to the cells suspensions to assess energy-
dependent efflux. CCCP was not added to the cells served
as a control. The increase in ethidium bromide fluores-
cence intensity was measured in a Gemini XPS spec-
trofluorimeter at 30°C with excitation at 500 nm and
emission at 580 nm. Each measurement was repeated
three times.
Statistical analysis
For all experiments, a P value of < 0.05 was considered
indicative of statistical significance, and all statistical anal-
yses were determined with Student's t test.
Results
The MICs for glutaraldehyde in clinical isolates
H. pylori strains were harvested during endoscopic exami-
nations at National Taiwan University Hospital from
1991 to 2000 [39]. 49 clinical isolates were cultured suc-
cessfully from stock and stored at -80°C. The patients
from which these strains were isolated suffered from gas-
tritis (15 strains), duodenal ulcer (16 strains), gastric ulcer
(9 strains), mucosa-associated lymphoid tissue lym-
phoma (MALToma) (3 strains), and gastric cancer (6
strains). Subsequently, the MICs of glutaraldehyde were
determined for these strains. The MICs of glutaraldehyde
for most of the clinical isolates were the range of 3–6 μg/
ml glutaraldehyde (Fig. 1). However, the diseases caused
The MICs of glutaraldehyde in clinical isolates from National  Taiwan University Hospital Figure 1
The MICs of glutaraldehyde in clinical isolates from 
National Taiwan University Hospital.BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
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by the strains of H. pylori and the MICs of glutaraldehyde
in these clinical isolates were not correlated (Table 1).
The RNA and protein expression levels of imp/ostA in 
clinical isolates after glutaraldehyde treatment
In our previous study [14], we found that the barrier func-
tion of the outer membrane against drugs might be
decreased in the imp/ostA mutant strain, suggesting that
glutaraldehyde may enter the mutant strain more rapidly
than it enters the wild-type strain. Four strains with the
MICs of 7–10 μg/ml (designed numbers 1~4), four with
the MICs of 4–6 μg/ml (numbers 5~8), and three with the
MICs of 1–3 μg/ml (numbers 9~11) were selected to clar-
ify the correlation of imp/ostA expression with glutaralde-
hyde resistance. Subsequently, RNA was extracted from
bacteria after 48 h with or without 0.5 μg/ml glutaralde-
hyde treatment. However, RNA expression of imp/ostA in
strains without glutaraldehyde treatment was not detected
by slot blot (data not shown). Therefore, we further exam-
ined RNA expression of imp/ostA by quantitative real-time
PCR. The result indicated that RNA expression of imp/ostA
induced by glutaraldehyde was higher in strains with the
MICs of 4–10 μg/ml than that in strains with the MICs of
1–3 μg/ml (P= 0.001455) (Fig. 2A). Expression of Imp/
OstA protein in these 11 strains after glutaraldehyde treat-
ment was also examined (Fig. 2B). The intensity of protein
expression in three independent experiments was ana-
lyzed by Image Quant 5.1, and the ratio of Imp/OstA pro-
tein expression in the 11 strains with and without
glutaraldehyde treatment was calculated. The ratio of
Imp/OstA expression induced by glutaraldehyde was
higher for strains with the MICs of 4–10 μg/ml (numbers
1~8) than strains with the MICs of 1–3 μg/ml (numbers
9~11) (P = 6.1 × 10-5) (Fig. 2C). These results suggested
that the expression of imp/ostA  and Imp/OstA was
involved in glutaraldehyde resistance in clinical isolates
after glutaraldehyde treatment.
Full genome expression after glutaraldehyde treatment
We next examined the alterations in RNA expression in H.
pylori  NTUH-S1 induced by glutaraldehyde. After treat-
ment with glutaraldehyde for 48 h, 40 genes were upregu-
lated at least 2.5-fold, and 31 genes were downregulated
at least 2.5-fold (see Additional File 1), compared to the
untreated bacteria. The upregulated genes included imp/
ostA, which was upregulated 9.218-fold. These results are
in agreement with the quantitative real-time PCR data,
showing that this gene was notably expressed after glutar-
aldehyde treatment. Another interesting finding was that
glutaraldehyde upregulated another lipid transport gene
msbA (HP1082) by 2.661-fold. Previous reports indicated
that this subfamily of ABC transporters is involved in
transport of many different substrates, such as peptides,
lipids, hydrophobic drugs, polysaccharides, and proteins
[40]. MsbA is a lipid flippase that transports the lipid A-
core moiety from the inner to the outer leaflet of the inner
membrane in E. coli [17,41]. Imp/OstA also participates in
transport of LPS to the cell surface in E. coli [17] and N.
meningitidis [20]. We proposed that MsbA might be corre-
lated with LPS transport in H. pylori. The deficiency in a
LPS biosynthesis gene could result in antibiotic suscepti-
bility, especially for hydrophobic antibiotics [42-44].
Therefore, weregarded msbA as a suitable candidate for
investigating glutaraldehyde or other hydrophobic drug
transport in bacteria.
Table 1: The MICs of glutaraldehyde in clinical isolates during 1991–2000.
Disease Number of isolates The MICs of glutaraldehyde in isolates (numbers)
Gastritis 15 7 μg/ml (n = 2), 6 μg/ml (n = 1)
5 μg/ml (n = 3), 4 μg/ml (n = 4)
3 μg/ml (n = 5)
Duodenal ulcer 16 10 μg/ml (n = 1), 7 μg/ml (n = 1)
6 μg/ml (n = 2), 5 μg/ml (n = 3)
4 μg/ml (n = 5), 2 μg/ml (n = 2)
1.5 μg/ml (n = 1), 1 μg/ml (n = 1)
Gastric ulcer 9 10 μg/ml (n = 1), 7 μg/ml (n = 1)
6 μg/ml (n = 3), 5 μg/ml (n = 1)
3 μg/ml (n = 1), 1.5 μg/ml (n = 1)
1 μg/ml (n = 1)
MALToma 3 7 μg/ml (n = 1), 5 μg/ml (n = 2)
Gastric cancer 6 6 μg/ml (n = 3), 5 μg/ml (n = 1)
3 μg/ml (n = 2)BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
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Reconfirmation of msbA expression in the clinical isolates 
by slot blots hybridization
Microarray analysis demonstrated that msbA was upregu-
lated by glutaraldehyde treatment, and the level of msbA
expression in the clinical isolates after glutaraldehyde
treatment was further determined by slot blot. RNA from
the 11 strains used in the imp/ostA expression experiment
(numbers 1~11) was extracted before or after glutaralde-
hyde treatment and hybridized with probes specific for
23S rRNA or msbA. The msbA  transcripts were weakly
detectable in the control without glutaraldehyde treat-
ment; therefore, the RNA ratio (msbA/23S rRNA) without
glutaraldehyde treatment was defined as 1, and the RNA
ratio with glutaraldehyde treatment was calculated. The
results confirmed the increased expression of msbA
induced by glutaraldehyde (Fig. 3A). Furthermore, the
level of msbA expression induced by glutaraldehyde was
higher in strains with the MICs of 4–10 μg/ml than that in
strains with the MICs of 1–3 μg/ml (P = 6.63 × 10-8) (Fig.
3B).
Effect of imp/ostA on the transcription of msbA after 
glutaraldehyde treatment
The expression of both imp/ostA and msbA was increased
in NTUH-S1 after glutaraldehyde treatment according to
the results of the microarray analysis. To determine
whether imp/ostA affects msbA gene expression after glutar-
aldehyde treatment and vice versa, RNA levels of imp/ostA
and msbA in wild-type and mutant strains after 0.5 μg/ml
glutaraldehyde treatment were analyzed by slot blot. The
imp/ostA transcript was not affected in the msbA deletion
mutant in comparison with the wild-type strain after glu-
taraldehyde treatment (Fig. 4). Likewise, the msbA tran-
script was not affected in the imp/ostA deletion mutant in
comparison with the wild-type strain after glutaraldehyde
treatment. This result indicated that imp/ostA and msbA
were induced by glutaraldehyde through independent
pathways.
The MICs of glutaraldehyde in isogenic mutants
We had previously observed that the imp/ostA  mutant
became more sensitive to glutaraldehyde than wild-type
strain [14]. Southern blot hybridizations were performed
to confirm that imp/ostA  or  msbA  were absent in the
The RNA and protein expression levels of imp/ostA in clinical isolates after glutaraldehyde treatment Figure 2
The RNA and protein expression levels of imp/ostA in clinical isolates after glutaraldehyde treatment. (A) Quan-
titative real-time PCR analysis of the relative expression of imp/ostA mRNA after glutaraldehyde treatment in 11 clinical iso-
lates. The MICs of the corresponding strains are shown in the lower portion of the figure. Each bar represents the relative 
expression after glutaraldehyde treatment. (B) Western blot analysis of Imp/OstA protein expression. (+) represents glutaral-
dehyde treatment; (-) represents no glutaraldehyde treatment. (C) The ratio of Imp/OstA protein expression with and without 
glutaraldehyde treatment. The results were from three independent experiments.BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
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mutants (Fig. 5). We further investigated whether the sen-
sitivities to glutaraldehyde ofisogenic msbA and an imp/
ostA, msbA double mutants were altered. The MIC for the
msbA single mutant (3.05 ± 0.27 μg/ml) was lower than
for wild-type (5.45 ± 0.21 μg/ml) (wild-type vs.msbA sin-
gle mutant, P = 2.84 × 10-7). For comparison, the MIC for
the imp/ostA single mutant (1.40 ± 0.42 μg/ml) was also
significantly lower than that of wild-type, as previously
reported [14]. Furthermore, the MICs for imp/ostA  and
msbA double mutant (0.60 ± 0.14 μg/ml) was also signif-
icantly lower than that of wild-type and showed the most
significant difference (P = 5.77 × 10-10). Complementa-
tion of the msbA mutation significantly restored the resist-
ance to glutaraldehyde (Fig. 6A). These results suggested
that imp/ostA and msbA were both involved in glutaralde-
hyde resistance, and the deficiency of these two genes in
H. pylori led to hypersensitivity to glutaraldehyde.
The MICs of hydrophobic antibiotics in isogenic mutants
According to previous reports [41,45], MsbA interacts
with multiple drugs, for example, multidrug resistance
(MDR) substrates (doxorubicin, vinblastine, erythromy-
cin, ethidium bromide) and non-MDR substrates (lipid A,
Hoechst). In addition, MsbA increases resistance to eryth-
romycin by 86-fold when it is expressed in L. lactis [22]. In
contrast, expression of MsbA in Pseudomonas aeruginosa
did not confer resistance to erythromycin, but introducing
E. coli msbA into P. aeruginosa decreased the susceptibility
The expression of msbA in 11 clinical isolates Figure 3
The expression of msbA in 11 clinical isolates. (A) Slot blots analysis of msbA expression in 11 clinical isolates. Hybridiza-
tion was performed with DIG probes specific for 23S rRNA and msbA. (+) represents glutaraldehyde treatment. (-) represents 
no glutaraldehyde treatment. (B) Bacteria were treated or not treated with glutaraldehyde by three independent experiments. 
The RNA ratio (msbA/23S rRNA) without glutaraldehyde treatment was defined as 1, and the RNA ratio with glutaraldehyde 
treatment was calculated.BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
Page 9 of 14
(page number not for citation purposes)
of this bacterium to erythromycin by 4-fold [46]. Hence,
we investigated whether the isogenic msbA mutant was
more sensitive to erythromycin than wild-type H. pylori.
The result showed that the MICs were 0.112 ± 0.029 μg/
ml and 0.017 ± 0.008 μg/ml for wild-type and the msbA
deletion mutant (wild-type vs. msbA deletion mutant, P=
0.00059, respectively). This indicated that MsbA partici-
pated in erythromycin resistance in H. pylori. In a previous
study [14], it has been reported that the mutation of imp/
ostA resulted in a lower MIC of erythromycin in H. pylori.
In this study, deletion of both imp/ostA  and  msbA
enhanced the susceptibility to erythromycin (P= 0.00055)
(Fig. 6B).
Previous reports demonstrated that in Gram-negative bac-
teria, a deficiency of the LPS biosynthesis gene would
result in antibiotic susceptibility, especially for hydropho-
bic antibiotics [42-44]. Therefore, we determined the
MICs of two hydrophobic antibiotics, novobiocin and
rifampicin, to investigate whether imp/ostA and msbA par-
ticipated in resistance to hydrophobic antibiotics. Both
imp/ostA and msbA single mutants were more sensitive to
novobiocin and rifampicin than wild-type (Fig. 6C and
6D). These results indicated that imp/ostA and msbA are
important for H. pylori resistence to hydrophobic antibi-
otics. The MIC of rifampicin for the imp/ostA and msbA
double mutant (0.00037 ± 0.00013 μg/ml) decreased sig-
nificantly.
In order to determine the transport route of hydrophobic
drugs in bacteria, the hydrophobic compound ethidium
bromide was used. In this way, the MIC of ethidium bro-
mide for H. pylori was also examined. The result showed
that the msbA mutant was more susceptible to ethidium
bromide than the wild-type strain. This result suggests
that MsbA might be involved in active efflux by H. pylori,
as evidenced by an approximately 36-fold reduction in the
MIC of the msbA mutant compared to the wild-type strain
(Fig. 6E).
LPS production in H. pylori wild-type and isogenic 
mutants
To investigate whether imp/ostA and msbA participated in
LPS biogenesis, the equivalent amounts of proteinase K-
digested whole cells were analyzed by silver staining (Fig.
7A). The total amount of LPS was drastically reduced in
the  imp/ostA  single mutant compared with that in the
wild-type strain (Fig. 7A, lane 3). This result indicated that
imp/ostA participated in LPS biogenesis and is consistent
with a similar finding in N. meningitidis [20]. Mutation of
msbA decreased LPS production, although small amounts
of LPS could be detected (Fig. 7A, lane 5). Furthermore,
deletion of both imp/ostA and msbA severely reduced LPS
production. The LPS in H. pylori was detected by using
anti-Lea (Fig. 7B) or anti-Leb antibody (Fig. 7C). H. pylori
The effect of imp/ostA on the transcription of msbA after glu- taraldehyde treatment and vice versa Figure 4
The effect of imp/ostA on the transcription of msbA 
after glutaraldehyde treatment and vice versa. Slot 
blots analysis of total RNA preparations of H. pylori NTUH-
S1 wild-type and mutants after 0.5 μg/ml glutaraldehyde 
treatment for 48 h. Each well was loaded with 10 μg total 
bacterial RNA. The membrane was hybridized with DIG-
labeled probes specific for H. pylori imp/ostA, msbA, and 23S 
rRNA.
Southern hybridization of Hind III-digested DNA from strains  NTUH-S1 and mutants with imp/ostA (left) and msbA (right)  probes Figure 5
Southern hybridization of Hind III-digested DNA 
from strains NTUH-S1 and mutants with imp/ostA 
(left) and msbA (right) probes. Approximately 5 μg of 
genomic DNA from H. pylori NTUH-S1 and the mutants was 
digested by Hind III. Hybridization and detection were per-
formed with the DIG Luminescent Detection kit (Roche) 
according to the manufacturer's instructions.BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
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26695 strain expressing Lex and Ley but not Lea or Leb anti-
gens was used as a negative control to ensure the specifi-
city of the anti-Lea or anti-Leb antibody (Fig. 7B and 7C,
lane 1). The data indicated that the NTUH-S1 strain
expressed both the Lea and Leb antigens. In addition, the
amounts of O-antigen (~34 kDa) in the imp/ostA or msbA
single mutant were reduced, and it was especially reduced
in the imp/ostA  and  msbA  double mutant. The growth
curves of the wild-type and mutant strains were also exam-
ined, and the growth rates of these mutants did not differ
from that of the wild-type strain (data not shown). This
result demonstrated that both imp/ostA  and msbA  were
involved in the production of LPS.
Outer membrane permeability to ethidium bromide
To investigate whether the permeability of the outer mem-
brane was altered in the mutant strains, we measured the
fluorescence intensity at a 40-min time point after addi-
tion of ethidium bromide and CCCP (Fig. 8A). The fluo-
rescence intensity of the imp/ostA  deletion mutant
(1142.73 ± 12.38 relative fluorescence units [RFUs]) was
higher than that of the wild-type (891.29 ± 20.62 RFUs, P
= 0.0001). The fluorescence intensity of the msbA deletion
mutant was also significantly higher than the wild-type (P
= 0.00164). These results might due to the increase of
outer membrane permeability when imp/ostA or msbA was
mutated. Furthermore, the fluorescence intensity of the
imp/ostA and msbA double mutant was also significantly
higher than that of wild-type (P = 5.83 × 10-5). Therefore,
the increased sensitivity to hydrophobic compounds con-
Determination of the MICs glutaraldehyde, erythromycin, novobiocin, rifampicin, and ethidium bromide in H. pylori and isogenic  mutants (A-E) Figure 6
Determination of the MICs glutaraldehyde, erythromycin, novobiocin, rifampicin, and ethidium bromide in H. 
pylori and isogenic mutants (A-E). Experiments were repeated three to five times. *, P < 0.05 vs. wild-type, and **, P < 
0.001 vs. wild-type. Error bars indicate the standard deviation.BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
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ferred by imp/ostA and msbA mutations can be explained
by the enhanced membrane permeability for the toxic
substances moving in.
The role of msbA in ethidium bromide efflux
As ethidium bromide is a hydrophobic aromatic com-
pound, we used this compound to mimic glutaraldehyde
or hydrophobic antibiotics moving in and efflux. The
Ethidium bromide accumulation assay was performed to
determine whether the msbA deletion mutant was more
susceptible to glutaraldehyde or hydrophobic antibiotics
due to the loss of an active efflux mechanism. The result
showed that the msbA deletion mutant accumulated more
amounts of ethidium bromide than wild-type (Fig. 8B).
When CCCP was added to the cells containing ethidium
bromide at 12 min, the accumulation of ethidium bro-
mide increased in wild-type and reached to the level
almost equal to that of msbA deletion mutant. This indi-
cated that ethidium bromide was retained in the cells
when efflux was blocked after the collapse of the cells'
metabolic energy by CCCP. In contrast, CCCP had no sig-
nificant effect on the level of ethidium bromide accumu-
lated in the msbA deletion mutant. In addition, ethidium
bromide accumulation in the msbA  complementation
strain reached a level almost equal to that of wild-type.
CCCP was not added to wild-type or complementation
strain containing ethidium bromide at 12 min served as a
control. These data indicated that MsbA was involved in
hydrophobic drug efflux and that it pumped out ethidium
bromide in an energy-dependent process. We concluded
that MsbA might pump out glutaraldehyde or hydropho-
bic antibiotics through an active efflux mechanism in H.
pylori.
Discussion
We previously identified that imp/ostA was associated with
glutaraldehyde resistance in a clinical H. pylori strain [14].
In order to further investigate the mechanism of glutaral-
dehyde resistance, the MICs and the levels of imp/ostA
expression in clinical isolates were monitored. The result
indicated that RNA and protein expression of imp/ostA
induced by glutaraldehyde was higher in strains with the
MICs of 4–10 μg/ml than that in strains with the MICs of
1–3 μg/ml. According to these results, we suggested that
imp/ostA  expression was correlated with glutaraldehyde
resistance in H. pylori clinical isolates.
After treating NTUH-S1 with glutaraldehyde, 40 genes
were found to be upregulated at least 2.5-fold by microar-
ray analysis. For 14 of these genes, DNA or protein
sequence alignment yielded no information about their
function. The other genes could be divided into three
groups: transporters, biosynthesis and metabolism genes,
and motility and chemotaxis genes. Two genes were
related to iron transport; nonheme iron-containing ferri-
tin (HP0653, pfr), which participates in iron metabolism
and in gastric colonization by H. pylori [47]; and an iron
dicitrate ABC transporter (HP0889, fecD). Genes includ-
ing  aimF,  bioC,  ispB, NADH-flavin oxidoreductase
(HP0642), and cytochrome c551 peroxidase (HP1461)
were involved in biosynthesis and metabolism. Lastly,
flagellar hook-associated protein 1 (HP1119, flgK) [48]
and flagellar hook-associated protein 2 (HP0752, fliD)
[49,50] were related to motility and chemotaxis. How-
ever, these genes might not be directly involved in resist-
ance to glutaraldehyde, and their association with
glutaraldehyde resistance needs further investigation. In
addition, 31 genes were downregulated at least 2.5-fold
after glutaraldehyde treatment. Several adjacent genes
Silver-stained of proteinase-K digested whole cell lysate from  H. pylori wild-type and isogenic mutants Figure 7
Silver-stained of proteinase-K digested whole cell 
lysate from H. pylori wild-type and isogenic mutants. 
(A) Lanes 1–7 were all loaded with 2.5 × 108 proteinase K-
digested bacteria (~130 μg total protein). Lane 1, 26695; lane 
2, wild-type; lane 3, imp/ostA single mutant strain; lane 4, imp/
ostA complementation strain; lane 5, msbA single mutant 
strain; lane 6, msbA complementation strain; lane 7,imp/ostA 
and msbA double mutant strain. Molecular weights of the 
prestained markers are indicated. (B-C) Immunoblots of LPS 
from H. pylori with anti-Lea or anti-Leb monoclonal antibodies. 
(B) anti-Lea (1:3000) as the primary antibody and anti-mouse 
IgG (1:5000) as the secondary antibody, or (C) anti-Leb 
(1:3000) as the primary antibody and anti-mouse IgG 
(1:5000) as the secondary antibody.BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
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Permeability and efflux of ethidium bromide Figure 8
Permeability and efflux of ethidium bromide. (A) Determination of the outer membrane permeability in H. pylori wild-
type and isogenic mutants. Each measurement was repeated three times. *, P < 0.05 vs. wild-type, and **, P < 0.001 vs. wild-
type. (B) Ethidium bromide accumulation assay. Cells were preloaded with 10 μg/ml ethidium bromide. At the 12-min time 
point, 10 μM of CCCP was added to the cells suspensions to assess energy-dependent efflux. CCCP was not added to the cells 
serving as controls (dotted lines). Each measurement was repeated three times.BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
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seemed to be co-regulated, which is indicative of operon
structures. For example, HP0690-HP0693 [51] partici-
pated in fatty acid metabolism in the TCA cycle. HP0695-
HP0696 [51] participated in hydantoin utilization. In
addition, some genes are transcribed at different loci but
are involved in outer-membrane composition, which
included hopG, hofH, and homA. Lastly, two subunits of
the 2-oxoglutarate oxidoreductase, oorB and oorD [52], are
also involved in the TCA cycle for energy metabolism. The
correlation between TCA cycle-related genes and glutaral-
dehyde resistance also needs to be investigated further.
Silver staining revealed that both imp/ostA and msbA par-
ticipated in the biogenesis of LPS in H. pylori. Similarly
mutation of the E. coli LPS biosynthesis gene, lpxA2,
resulted in extreme susceptibility to antibiotics, especially
hydrophobic antibiotics [42-44]. Therefore, mutation of
the LPS biosynthesis genes, imp/ostA  and  msbA, might
account for the reduction of the MICs for hydrophobic
antibiotics.
In the beginning, we observed that the MICs of two glutar-
aldehyde-resistant strains were 10 μg/ml glutaraldehyde.
In fact, this is the half concentration used in our hospital
for disinfection during endoscopy. We proposed that
some bacteria could survive at the low concentrations in
the glutaraldehyde-treated endoscopic environment.
According to the MICs tests, LPS analysis, outer mem-
brane permeability assay, and ethidium bromide accumu-
lation assay, the increased sensitivity to hydrophobic
compounds conferred by mutations of imp/ostA and msbA
can be explained by the defect in LPS production and
increased outer membrane permeability. In addition, the
increased sensitivity to hydrophobic compounds con-
ferred by mutation of msbA might to the result of accumu-
lation of chemicals that are not pumped out by the MsbA
efflux pump. The combination of these effects of the imp/
ostA and msbA would reduce the MICs of cells toward glu-
taraldehyde and hydrophobic antibiotics. These findings
might help us to understand the mechanism of bacterial
tolerance to chemical disinfectant and hydrophobic
drugs.
Conclusion
The expression levels of imp/ostA and msbA were correlated
with glutaraldehyde resistance in clinical isolates after glu-
taraldehyde treatment. Imp/OstA and MsbA play an
important role in hydrophobic drugs resistance and LPS
biogenesis in H. pylori.
Authors' contributions
HC, TL, and JW conceived and designed the experiments.
HC carried out the experiments, analyzed the data, and
drafted the manuscript. JY provided clinical isolate strains.
TL and JW modified the manuscript. All the authors have
read and approved the final manuscript.
Additional material
Acknowledgements
This work was supported by grants from the National Science Council, Tai-
wan.
References
1. Marshall BJ, Warren JR: Unidentified curved bacilli in the stom-
ach of patients with gastritis and peptic ulceration.  Lancet
1984, 1(8390):1311-1315.
2. Blaser MJ: Hypotheses on the pathogenesis and natural his-
tory of Helicobacter pylori-induced inflammation.  Gastroen-
terology 1992, 102(2):720-727.
3. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI,
Blaser MJ: Helicobacter pylori infection and gastric carcinoma
among Japanese Americans in Hawaii.  N Engl J Med 1991,
325(16):1132-1136.
4. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH,
Orentreich N, Sibley RK: Helicobacter pylori infection and the
risk of gastric carcinoma.  N Engl J Med 1991, 325(16):1127-1131.
5. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni
M, Isaacson PG: Regression of primary low-grade B-cell gastric
lymphoma of mucosa-associated lymphoid tissue type after
eradication of Helicobacter pylori.  Lancet 1993,
342(8871):575-577.
6. Cave DR: How is Helicobacter pylori transmitted?  Gastroenter-
ology 1997, 113(6 Suppl):S9-14.
7. Kaczmarek RG, Moore RM Jr, McCrohan J, Goldmann DA, Reynolds
C, Caquelin C, Israel E: Multi-state investigation of the actual
disinfection/sterilization of endoscopes in health care facili-
ties.  Am J Med 1992, 92(3):257-261.
8. Fantry GT, Zheng QX, James SP: Conventional cleaning and dis-
infection techniques eliminate the risk of endoscopic trans-
mission of Helicobacter pylori.  Am J Gastroenterol 1995,
90(2):227-232.
9. Langenberg W, Rauws EA, Oudbier JH, Tytgat GN: Patient-to-
patient transmission of Campylobacter pylori infection by
fiberoptic gastroduodenoscopy and biopsy.  J Infect Dis 1990,
161(3):507-511.
10. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E:
Epidemiology of Helicobacter pylori in an asymptomatic
population in the United States. Effect of age, race, and soci-
oeconomic status.  Gastroenterology 1991, 100(6):1495-1501.
11. Reynolds CD, Rhinehart E, Dreyer P, Goldmann DA: Variability in
reprocessing policies and procedures for flexible fiberoptic
endoscopes in Massachusetts hospitals.  Am J Infect Control 1992,
20(6):283-290.
12. Nurnberg M, Schulz HJ, Ruden H, Vogt K: Do conventional clean-
ing and disinfection techniques avoid the risk of endoscopic
Helicobacter pylori transmission?  Endoscopy 2003,
35(4):295-299.
13. Kaneko H, Mitsuma T, Kotera H, Uchida K, Furusawa A, Morise K:
Are routine cleaning methods sufficient to remove Helico-
bacter pylori from endoscopic equipment?  Endoscopy 1993,
25(6):435.
14. Chiu HC, Lin TL, Wang JT: Identification and characterization
of an organic solvent tolerance gene in Helicobacter pylori.
Helicobacter 2007, 12(1):74-81.
Additional file 1
microarray data. Genes were upregulated and downregulated after glu-
taraldehyde treatment by microarray analysis
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2180-9-136-S1.pdf]BMC Microbiology 2009, 9:136 http://www.biomedcentral.com/1471-2180/9/136
Page 14 of 14
(page number not for citation purposes)
15. Aono R, Negishi T, Aibe K, Inoue A, Horikoshi K: Mapping of
organic solvent tolerance gene ostA in Escherichia coli K-12.
Biosci Biotechnol Biochem 1994, 58(7):1231-1235.
16. Sampson BA, Misra R, Benson SA: Identification and characteri-
zation of a new gene of Escherichia coli K-12 involved in
outer membrane permeability.  Genetics 1989, 122(3):491-501.
17. Sperandeo P, Lau FK, Carpentieri A, De Castro C, Molinaro A, Deho
G, Silhavy TJ, Polissi A: Functional analysis of the protein
machinery required for transport of lipopolysaccharide to
the outer membrane of Escherichia coli.  J Bacteriol 2008,
190(13):4460-4469.
18. Braun M, Silhavy TJ: Imp/OstA is required for cell envelope bio-
genesis in Escherichia coli.  Mol Microbiol 2002, 45(5):1289-1302.
19. Wu T, McCandlish AC, Gronenberg LS, Chng SS, Silhavy TJ, Kahne D:
Identification of a protein complex that assembles lipopoly-
saccharide in the outer membrane of Escherichia coli.  Proc
Natl Acad Sci USA 2006, 103(31):11754-11759.
20. Bos MP, Tefsen B, Geurtsen J, Tommassen J: Identification of an
outer membrane protein required for the transport of
lipopolysaccharide to the bacterial cell surface.  Proc Natl Acad
Sci USA 2004, 101(25):9417-9422.
21. Karow M, Georgopoulos C: The essential Escherichia coli msbA
gene, a multicopy suppressor of null mutations in the htrB
gene, is related to the universally conserved family of ATP-
dependent translocators.  Mol Microbiol 1993, 7(1):69-79.
22. Woebking B, Reuter G, Shilling RA, Velamakanni S, Shahi S, Venter H,
Balakrishnan L, van Veen HW: Drug-lipid A interactions on the
Escherichia coli ABC transporter MsbA.  J Bacteriol 2005,
187(18):6363-6369.
23. Tefsen B, Bos MP, Beckers F, Tommassen J, de Cock H: MsbA is not
required for phospholipid transport in Neisseria meningi-
tidis.  J Biol Chem 2005, 280(43):35961-35966.
24. Polissi A, Georgopoulos C: Mutational analysis and properties
of the msbA gene of Escherichia coli, coding for an essential
ABC family transporter.  Mol Microbiol 1996, 20(6):1221-1233.
25. Zhou Z, White KA, Polissi A, Georgopoulos C, Raetz CR: Function
of Escherichia coli MsbA, an essential ABC family trans-
porter, in lipid A and phospholipid biosynthesis.  J Biol Chem
1998, 273(20):12466-12475.
26. Hsieh PF, Yang JC, Lin JT, Wang JT: Molecular mechanisms of
clarithromycin resistance in Helicobacter pylori.  J Formos Med
Assoc 1998, 97(7):445-452.
27. Ang S, Lee CZ, Peck K, Sindici M, Matrubutham U, Gleeson MA,
Wang JT: Acid-induced gene expression in Helicobacter
pylori: study in genomic scale by microarray.  Infect Immun
2001, 69(3):1679-1686.
28. Bockelmann U, Dorries HH, Ayuso-Gabella MN, Salgot de Marcay M,
Tandoi V, Levantesi C, Masciopinto C, Van Houtte E, Szewzyk U,
Wintgens T, et al.: Quantitative PCR monitoring of antibiotic
resistance genes and bacterial pathogens in three European
artificial groundwater recharge systems.  Appl Environ Microbiol
2009, 75(1):154-163.
29. Hsieh PF, Lin TL, Lee CZ, Tsai SF, Wang JT: Serum-induced iron-
acquisition systems and TonB contribute to virulence in
Klebsiella pneumoniae causing primary pyogenic liver
abscess.  J Infect Dis 2008, 197(12):1717-1727.
30. Hitchcock PJ, Brown TM: Morphological heterogeneity among
Salmonella lipopolysaccharide chemotypes in silver-stained
polyacrylamide gels.  J Bacteriol 1983, 154(1):269-277.
31. Simoons-Smit IM, Appelmelk BJ, Verboom T, Negrini R, Penner JL,
Aspinall GO, Moran AP, Fei SF, Shi BS, Rudnica W, et al.: Typing of
Helicobacter pylori with monoclonal antibodies against
Lewis antigens in lipopolysaccharide.  J Clin Microbiol 1996,
34(9):2196-2200.
32. Heneghan MA, McCarthy CF, Moran AP: Relationship of blood
group determinants on Helicobacter pylori lipopolysaccha-
ride with host lewis phenotype and inflammatory response.
Infect Immun 2000, 68(2):937-941.
33. Marshall DG, Hynes SO, Coleman DC, O'Morain CA, Smyth CJ,
Moran AP: Lack of a relationship between Lewis antigen
expression and cagA, CagA, vacA and VacA status of Irish
Helicobacter pylori isolates.  FEMS Immunol Med Microbiol 1999,
24(1):79-90.
34. Moran AP: Lipopolysaccharide in bacterial chronic infection:
insights from Helicobacter pylori lipopolysaccharide and
lipid A.  Int J Med Microbiol 2007, 297(5):307-319.
35. Wang G, Ge Z, Rasko DA, Taylor DE: Lewis antigens in Helico-
bacter pylori: biosynthesis and phase variation.  Mol Microbiol
2000, 36(6):1187-1196.
36. LePecq JB, Paoletti C: A fluorescent complex between ethidium
bromide and nucleic acids. Physical-chemical characteriza-
tion.  J Mol Biol 1967, 27(1):87-106.
37. Giraud E, Cloeckaert A, Kerboeuf D, Chaslus-Dancla E: Evidence
for active efflux as the primary mechanism of resistance to
ciprofloxacin in Salmonella enterica serovar typhimurium.
Antimicrob Agents Chemother 2000, 44(5):1223-1228.
38. Guglierame P, Pasca MR, De Rossi E, Buroni S, Arrigo P, Manina G,
Riccardi G: Efflux pump genes of the resistance-nodulation-
division family in Burkholderia cenocepacia genome.  BMC
Microbiol 2006, 6:66.
39. Wang JT, Sheu JC, Lin JT, Wang TH, Wu MS: Direct DNA amplifi-
cation and restriction pattern analysis of Helicobacter pylori
in patients with duodenal ulcer and their families.  J Infect Dis
1993, 168(6):1544-1548.
40. Davidson AL, Dassa E, Orelle C, Chen J: Structure, function, and
evolution of bacterial ATP-binding cassette systems.  Micro-
biol Mol Biol Rev 2008, 72(2):317-364. table of contents
41. Reyes CL, Ward A, Yu J, Chang G: The structures of MsbA:
Insight into ABC transporter-mediated multidrug efflux.
FEBS Lett 2006, 580(4):1042-1048.
42. Leive L, Telesetsky S, Coleman WG Jr, Carr D: Tetracyclines of
various hydrophobicities as a probe for permeability of
Escherichia coli outer membranes.  Antimicrob Agents Chemother
1984, 25(5):539-544.
43. Vuorio R, Vaara M: The lipid A biosynthesis mutation lpxA2 of
Escherichia coli results in drastic antibiotic supersusceptibil-
ity.  Antimicrob Agents Chemother 1992, 36(4):826-829.
44. Clements JM, Coignard F, Johnson I, Chandler S, Palan S, Waller A,
Wijkmans J, Hunter MG: Antibacterial activities and character-
ization of novel inhibitors of LpxC.  Antimicrob Agents Chemother
2002, 46(6):1793-1799.
45. Reuter G, Janvilisri T, Venter H, Shahi S, Balakrishnan L, van Veen
HW: The ATP binding cassette multidrug transporter LmrA
and lipid transporter MsbA have overlapping substrate spe-
cificities.  J Biol Chem 2003, 278(37):35193-35198.
46. Ghanei H, Abeyrathne PD, Lam JS: Biochemical characterization
of MsbA from Pseudomonas aeruginosa.  J Biol Chem 2007,
282(37):26939-26947.
47. Waidner B, Greiner S, Odenbreit S, Kavermann H, Velayudhan J,
Stahler F, Guhl J, Bisse E, van Vliet AH, Andrews SC, et al.: Essential
role of ferritin Pfr in Helicobacter pylori iron metabolism
and gastric colonization.  Infect Immun 2002, 70(7):3923-3929.
48. Bleumink-Pluym NM, Verschoor F, Gaastra W, Zeijst BA van der, Fry
BN: A novel approach for the construction of a Campylo-
bacter mutant library.  Microbiology 1999, 145(Pt 8):2145-2151.
49. Kim JS, Chang JH, Chung SI, Yum JS: Molecular cloning and char-
acterization of the Helicobacter pylori fliD gene, an essential
factor in flagellar structure and motility.  J Bacteriol 1999,
181(22):6969-6976.
50. Ryan KA, Karim N, Worku M, Penn CW, O'Toole PW: Helico-
bacter pylori flagellar hook-filament transition is controlled
by a FliK functional homolog encoded by the gene HP0906.
J Bacteriol 2005, 187(16):5742-5750.
51. Pflock M, Bathon M, Schar J, Muller S, Mollenkopf H, Meyer TF, Beier
D: The orphan response regulator HP1021 of Helicobacter
pylori regulates transcription of a gene cluster presumably
involved in acetone metabolism.  J Bacteriol 2007,
189(6):2339-2349.
52. Hughes NJ, Clayton CL, Chalk PA, Kelly DJ: Helicobacter pylori
porCDAB and oorDABC genes encode distinct pyruvate:fla-
vodoxin and 2-oxoglutarate:acceptor oxidoreductases which
mediate electron transport to NADP.  J Bacteriol 1998,
180(5):1119-1128.